Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19)

New feature! Try PharmData's Temporary Safeguarding Payments service to help identify if your pharmacy is eligible to make a claim. Over 500 pharmacies have made successful claims under the NHSBSA scheme, averaging more than £200 per pharmacy per month. Try now for free »

Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19)

2019-10-03 10:29:57 (2 year(s) ago)

Summary

The MHRA has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate.

Read full MHRA article

Respond to this alert